Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Winkelmann

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Annals of Internal Medicine|August 15, 1996
Diuretics and sudden cardiac deathB R Winkelmann
Pharmacogenomics|March 22, 2001
Genomics and large scale phenotypic databasesB R Winkelmann
Annals of Internal Medicine|January 1, 1987
Almitrine bismesylate and hypoxemiaB R Winkelmann, F Hertrich
Circulation|August 5, 1997
ACE*D and cardiovascular diseaseB R Winkelmann, M Verho
Annals of Internal Medicine|June 1, 1987
Life-threatening flecainide toxicity. A pharmacodynamic approachB R Winkelmann, H Leinberger
Pharmacogenomics|March 22, 2001
Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidenceB R Winkelmann, J Hager
Clinical Pharmacokinetics|May 1, 1996
Clinical pharmacokinetics of molsidomineB Rosenkranz, B R Winkelmann, M J Parnham
Expert Opinion on Investigational Drugs|July 2, 2005
Overview of clinical trials with glycoprotein IIb-IIIa receptor antagonists in the prevention and management of coronaryB R Winkelmann, R Zahn, H U Stilz
Cardiovascular Drugs and Therapy|September 1, 1988
Isometric exercise for the evaluation of vasodilatory therapy in severe congestive heart failureF F Hertrich, B R Winkelmann, H Leinberger
M.D. Computing : Computers in Medical Practice|November 1, 1990
Cardiac volumeB R Winkelmann, G Kneissl, T Kaltenbach, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Annals of Internal Medicine|August 15, 1996
Diuretics and sudden cardiac deathB R Winkelmann
Pharmacogenomics|March 22, 2001
Genomics and large scale phenotypic databasesB R Winkelmann
Annals of Internal Medicine|January 1, 1987
Almitrine bismesylate and hypoxemiaB R Winkelmann, F Hertrich
Circulation|August 5, 1997
ACE*D and cardiovascular diseaseB R Winkelmann, M Verho
Annals of Internal Medicine|June 1, 1987
Life-threatening flecainide toxicity. A pharmacodynamic approachB R Winkelmann, H Leinberger
Pharmacogenomics|March 22, 2001
Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidenceB R Winkelmann, J Hager
Clinical Pharmacokinetics|May 1, 1996
Clinical pharmacokinetics of molsidomineB Rosenkranz, B R Winkelmann, M J Parnham
Expert Opinion on Investigational Drugs|July 2, 2005
Overview of clinical trials with glycoprotein IIb-IIIa receptor antagonists in the prevention and management of coronaryB R Winkelmann, R Zahn, H U Stilz
Cardiovascular Drugs and Therapy|September 1, 1988
Isometric exercise for the evaluation of vasodilatory therapy in severe congestive heart failureF F Hertrich, B R Winkelmann, H Leinberger
M.D. Computing : Computers in Medical Practice|November 1, 1990
Cardiac volumeB R Winkelmann, G Kneissl, T Kaltenbach, et al.
Pageof 5